Management of high defibrillation threshold.

Area of Science:

• Cardiology
• Medical Devices
• Electrophysiology

Background:

• Implantable cardioverter defibrillators (ICDs) are primary therapy for lethal ventricular arrhythmias.
• Ventricular arrhythmias range from premature complexes to ventricular fibrillation.
• Understanding of ventricular fibrillation and defibrillation mechanisms is evolving.

Purpose of the Study:

• To review therapeutic strategies for managing patients with high defibrillation thresholds (DFT).
• To address clinical scenarios involving high DFT in ICD patients.

Main Methods:

• Review of existing literature and clinical scenarios.
• Discussion of therapeutic strategies for high DFT management.

Main Results:

• High DFT in ICD patients is a significant concern, potentially leading to sudden cardiac death.
• Current clinical trials for high DFT management are limited.
• Active-can ICD configurations with transvenous leads improve defibrillation thresholds.

Conclusions:

• Effective management of high DFT is crucial for ICD patient outcomes.
• Further rigorous research is needed to establish optimal methodologies for high DFT treatment.
• This review provides insights into managing high DFT in common clinical situations.